TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive Varmus to NCAB: Budgetary “Haircuts” No Longer Sufficient to Cope With Fiscal Pressure September 16, 2011
TCL Archive Funding Opportunities: Lustgarten Foundation Request For Proposals; RFAs Available; NCI Grant Supplements. June 20, 2003
TCL Archive FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment. July 27, 2001
